to Oslo Medtech
Register here to subscribe to our newsletter!
Generating innovation. For better living and health.
iSentio AS has raised 1.5 million USD in new funding from new and existing investors. The main new investor is Sarsia Seed AS, a Norwegian seed capital fund which invests in early phase technology companies within energy / cleantech and Life Science sectors.
The funding will be used to grow sales, marketing and support, as well as enable the company to accelerate the development of new application areas. Sarsia Seed’s experience with start-up companies in Life Science will contribute with network and competence to strengthen us even further” says Bjarte Karlsen, CEO of iSentio.
The new Chairman of the board is Siri Fürst. With a background from finance, investor relations and strategic business development, Fürst brings with her a broad experience from the Life Science industry.